AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...
The U.S. health regulator has approved expanding the use of Revance Therapeutics' Daxxify to treat a painful neck muscle condition, intensifying the anti-wrinkle injection's rivalry with AbbVie's ...
The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration are investigating several cases across the U.S. of people suffering harmful reactions after receiving Botox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results